AVITHRAPID
AVITHRAPID is a European flagship project co-funded by the European Commission and the Swiss Confederation, dedicated to accelerating antiviral innovation and strengthening Europe’s preparedness for future epidemics and pandemics.
Public Opinion Survey | Your voice is essential
Pandemics continue to influence public health, policy, and scientific priorities. To better understand how citizens, professionals, and institutions perceive these challenges - and what they expect from future preparedness efforts - AVITHRAPID is conducting a new international public opinion survey.
We invite researchers, healthcare professionals, policymakers, students, and citizens to participate.
The survey is anonymous, and you may request the final public report.
Learn how science, innovation, and collaboration protect us from future outbreaks.
researchers | innovators | organizations
Find out how to collaborate in antiviral research and development to accelerate the development of next-generation solutions.
Latest News & Events from AVITHRAPID
AVITHRAPID introduced at SC25 exhibition
The AVITHRAPID consortium had a great opportunity to present its ambitious objectives and results during the International Conference for High Performance computing, networking, storage, and analysis in St. Louis, US, on November 17th-21st. SC is an unparalleled mix of thousands
AVITHRAPID met evaluators for the interim review
The Avithrapid consortium successfully passed the interim review after an in-depth interview with the evaluators in September. In the consolidated report, the reviewers acknowledged that “the project has achieved most of its objectives and milestones for the period, with relatively
European Researchers’ Night at Frascati Scienza
Frascati Scienza celebrated 20 years of science, passion, and curiosity with the 2025 edition of the European Researchers’ Night. The event filled squares, schools, museums, and institutions throughout Italy with a week packed with events dedicated to scientific dissemination: a